Gómez, H. L., Samanéz, C., Campana, F., Neciosup, S. P., Vera, L., Casanova, L., . . . Vallejos, C. S. (2012). Addition of amifostine to the CHOP regimen in elderly patients with aggressive non-Hodgkin lymphoma: A phase II trial showing reduction in toxicity without altering long-term survival.
Citación estilo ChicagoGómez, Henry L., et al. Addition of Amifostine to the CHOP Regimen in Elderly Patients With Aggressive Non-Hodgkin Lymphoma: A Phase II Trial Showing Reduction in Toxicity Without Altering Long-term Survival. 2012.
Cita MLAGómez, Henry L., et al. Addition of Amifostine to the CHOP Regimen in Elderly Patients With Aggressive Non-Hodgkin Lymphoma: A Phase II Trial Showing Reduction in Toxicity Without Altering Long-term Survival. 2012.
